Gossamer Bio, Inc
Price
FilingsNewest: 8-K, Other eventsSep 28 →InsidersNo open-market buys or sales.→HoldersD. E. Shaw & 8.4%683 8.0%DeepCurrents Investment 7.7%→Financing →PeersClosest companies: VKTX, AGIO, KROS→
From the filings
Figures
- Revenue
- $53.3Mlast 12 months
- Net income
- −$125.2Mlast 12 months
- Operating cash flow
- −$170.3Mlast 12 months
- Cash and equivalents
- $41.1Mat the last balance sheet
- Shares outstanding
- 488.8M shareson issue